Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200376381> ?p ?o ?g. }
- W4200376381 endingPage "1856" @default.
- W4200376381 startingPage "1843" @default.
- W4200376381 abstract "To describe the adverse events associated with brolucizumab, in particular the sequence of intraocular inflammation (IOI), retinal vasculitis (RV), and/or retinal vascular occlusion (RO).This was an unmasked post hoc analysis of the randomized HAWK/HARRIER clinical trials. Patients with neovascular AMD in the brolucizumab arms of the trials were included. IOI-related adverse events reported by study investigators were analyzed to determine early signs and the time course of IOI-related adverse events, using a subgroup of patients with definite/probable IOI cases identified in an independent unmasked post hoc review by an external safety review committee. A limited literature review on IOI following anti-VEGF therapy was also conducted.Among 50 patients with definite/probable IOI cases identified by the safety review committee, 12 had RV or RO adverse events reported by the investigators. For 6 of 12, IOI (other than RV) was reported before RV or RO. The duration from the first IOI adverse event to the first RV or RO adverse event ranged from 16 to 171 days for 5 patients and was 553 days for 1 patient. Four of the 6 patients received ≥ 1 brolucizumab injection on or after the date of the first IOI adverse event and before the first RV or RO adverse event.IOI may precede RV or RO in some patients treated with brolucizumab." @default.
- W4200376381 created "2021-12-31" @default.
- W4200376381 creator A5010137447 @default.
- W4200376381 creator A5012009183 @default.
- W4200376381 creator A5021131648 @default.
- W4200376381 creator A5028670749 @default.
- W4200376381 creator A5058642781 @default.
- W4200376381 creator A5061621783 @default.
- W4200376381 creator A5069039157 @default.
- W4200376381 creator A5080807595 @default.
- W4200376381 date "2021-12-21" @default.
- W4200376381 modified "2023-09-30" @default.
- W4200376381 title "Manifestations of intraocular inflammation over time in patients on brolucizumab for neovascular AMD" @default.
- W4200376381 cites W1513613431 @default.
- W4200376381 cites W1968189763 @default.
- W4200376381 cites W1989312280 @default.
- W4200376381 cites W2018143279 @default.
- W4200376381 cites W2027116176 @default.
- W4200376381 cites W2036940508 @default.
- W4200376381 cites W2047901258 @default.
- W4200376381 cites W2085712747 @default.
- W4200376381 cites W2089838877 @default.
- W4200376381 cites W2093958240 @default.
- W4200376381 cites W2097674931 @default.
- W4200376381 cites W2104106986 @default.
- W4200376381 cites W2106557635 @default.
- W4200376381 cites W2124415048 @default.
- W4200376381 cites W2129525239 @default.
- W4200376381 cites W2130626478 @default.
- W4200376381 cites W2139499737 @default.
- W4200376381 cites W2286056081 @default.
- W4200376381 cites W2287587792 @default.
- W4200376381 cites W2316338492 @default.
- W4200376381 cites W2322844674 @default.
- W4200376381 cites W2331904769 @default.
- W4200376381 cites W2332881543 @default.
- W4200376381 cites W2607337634 @default.
- W4200376381 cites W26619370 @default.
- W4200376381 cites W2887429619 @default.
- W4200376381 cites W2888854458 @default.
- W4200376381 cites W2928193900 @default.
- W4200376381 cites W2936430874 @default.
- W4200376381 cites W2943747669 @default.
- W4200376381 cites W2999438498 @default.
- W4200376381 cites W3014527467 @default.
- W4200376381 cites W3014659623 @default.
- W4200376381 cites W3017504588 @default.
- W4200376381 cites W3035836792 @default.
- W4200376381 cites W3040108021 @default.
- W4200376381 cites W3045140681 @default.
- W4200376381 cites W3047384749 @default.
- W4200376381 cites W3101914433 @default.
- W4200376381 cites W3132186594 @default.
- W4200376381 doi "https://doi.org/10.1007/s00417-021-05518-0" @default.
- W4200376381 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34932153" @default.
- W4200376381 hasPublicationYear "2021" @default.
- W4200376381 type Work @default.
- W4200376381 citedByCount "9" @default.
- W4200376381 countsByYear W42003763812022 @default.
- W4200376381 countsByYear W42003763812023 @default.
- W4200376381 crossrefType "journal-article" @default.
- W4200376381 hasAuthorship W4200376381A5010137447 @default.
- W4200376381 hasAuthorship W4200376381A5012009183 @default.
- W4200376381 hasAuthorship W4200376381A5021131648 @default.
- W4200376381 hasAuthorship W4200376381A5028670749 @default.
- W4200376381 hasAuthorship W4200376381A5058642781 @default.
- W4200376381 hasAuthorship W4200376381A5061621783 @default.
- W4200376381 hasAuthorship W4200376381A5069039157 @default.
- W4200376381 hasAuthorship W4200376381A5080807595 @default.
- W4200376381 hasBestOaLocation W42003763811 @default.
- W4200376381 hasConcept C126322002 @default.
- W4200376381 hasConcept C168563851 @default.
- W4200376381 hasConcept C197934379 @default.
- W4200376381 hasConcept C2776015282 @default.
- W4200376381 hasConcept C2778328719 @default.
- W4200376381 hasConcept C2779134260 @default.
- W4200376381 hasConcept C535046627 @default.
- W4200376381 hasConcept C71924100 @default.
- W4200376381 hasConceptScore W4200376381C126322002 @default.
- W4200376381 hasConceptScore W4200376381C168563851 @default.
- W4200376381 hasConceptScore W4200376381C197934379 @default.
- W4200376381 hasConceptScore W4200376381C2776015282 @default.
- W4200376381 hasConceptScore W4200376381C2778328719 @default.
- W4200376381 hasConceptScore W4200376381C2779134260 @default.
- W4200376381 hasConceptScore W4200376381C535046627 @default.
- W4200376381 hasConceptScore W4200376381C71924100 @default.
- W4200376381 hasIssue "6" @default.
- W4200376381 hasLocation W42003763811 @default.
- W4200376381 hasLocation W42003763812 @default.
- W4200376381 hasLocation W42003763813 @default.
- W4200376381 hasLocation W42003763814 @default.
- W4200376381 hasOpenAccess W4200376381 @default.
- W4200376381 hasPrimaryLocation W42003763811 @default.
- W4200376381 hasRelatedWork W2093319321 @default.
- W4200376381 hasRelatedWork W2135859081 @default.
- W4200376381 hasRelatedWork W2412156743 @default.
- W4200376381 hasRelatedWork W2531551665 @default.
- W4200376381 hasRelatedWork W2901245954 @default.